EIGR - Eiger BioPharmaceuticals Inc
Close
1.725
-0.175 -10.145%
Share volume: 137,824
Last Updated: Wed 10 Apr 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.90
-0.18
-9.21%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-05 | 2022-08-04 | 2022-11-03 | 2023-03-17 | 2023-05-11 | 2023-08-14 | 2023-11-09 | |
| Total revenue | 2.673 M | 4.091 M | 4.024 M | 2.696 M | 4.118 M | 4.643 M | 3.209 M | |
| Cost of revenue | 110.000 K | 151.000 K | 1.231 M | 345.000 K | 118.000 K | -310.000 K | 115.000 K | |
| Gross profit | 2.563 M | 3.940 M | 2.793 M | 2.351 M | 4.000 M | 4.953 M | 3.094 M | |
| 53.73% | -29.11% | -15.83% | 70.14% | 23.83% | -37.53% | |||
| Operating expenses | 24.383 M | 24.020 M | 29.162 M | 26.822 M | 26.263 M | 24.934 M | 20.022 M | |
| Selling general and admin | 6.813 M | 7.027 M | 6.964 M | 8.301 M | 9.515 M | 5.533 M | 5.454 M | |
| Research and development | 17.570 M | 16.993 M | 22.198 M | 18.521 M | 16.748 M | 19.401 M | 14.568 M | |
| Total expenses | 24.493 M | 24.171 M | 30.393 M | 27.167 M | 26.381 M | 24.624 M | 20.137 M | |
| -1.31% | 25.74% | -10.61% | -2.89% | -6.66% | -18.22% | |||
| Operating income | -21.820 M | -20.080 M | -26.369 M | -24.471 M | -22.263 M | -19.981 M | -16.928 M | |
| Ebit | -21.820 M | -20.080 M | -26.369 M | -24.471 M | -22.263 M | -19.981 M | -16.928 M | |
| Pretax income | -22.634 M | -21.867 M | -27.111 M | -25.141 M | -22.782 M | -20.693 M | -18.030 M | |
| -3.39% | 23.98% | -7.27% | -9.38% | -9.17% | -12.87% | |||
| Income tax | 9.000 K | 17.000 K | 0.000 | -3.000 K | 2.000 K | 2.000 K | 0.000 | |
| Net income basic | -22.643 M | -21.884 M | -27.111 M | -25.138 M | -22.784 M | -20.695 M | -18.030 M | |
| 3.35% | -23.89% | 7.28% | 9.36% | 9.17% | 12.88% | |||
| Net income | -22.643 M | -21.884 M | -27.111 M | -25.138 M | -22.784 M | -20.695 M | -18.030 M | |
| 3.35% | -23.89% | 7.28% | 9.36% | 9.17% | 12.88% |